Patents Assigned to Morinaga Milk Industry Co., Ltd.
  • Publication number: 20190083549
    Abstract: A novel agent useful for improving brain function is provided. The active ingredient in this agent is a Bifidobacterium breve and/or a Bifidobacterium breve-containing cultured material is provided.
    Type: Application
    Filed: November 28, 2018
    Publication date: March 21, 2019
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Yodai Kobayashi, Tetsuya Kuhara, Kanetada Shimizu, Takumi Sato
  • Publication number: 20180369298
    Abstract: To provide a technology capable of promoting growth of Bifidobacterium bacteria and lactic acid bacteria under an environment causing the growth or no change in cell count while suppressing decrease under an environment causing the decrease. Provided is an agent for promoting the growth of, and/or suppressing a decrease in, Bifidobacterium bacteria and/or lactic acid bacteria containing Arthrospira blue-green algae and/or Spirulina blue-green algae as an active ingredient. Also provided is an oral composition including Arthrospira blue-green algae and/or Spirulina blue-green algae together with at least one type of bacteria selected from the group consisting of Bifidobacterium bacteria and lactic acid bacteria.
    Type: Application
    Filed: December 19, 2016
    Publication date: December 27, 2018
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Kengo FUJII, Hirofumi MIYAUCHI, Yohei SATO
  • Publication number: 20180280483
    Abstract: An agent for protecting upper respiratory tracts or a food or drink composition for protecting upper respiratory tracts which is effective in ameliorating various symptoms relating to upper respiratory tracts is provided. An agent for protecting upper respiratory tracts and a food or drink composition for protecting upper respiratory tracts containing lactoferrin, lactoperoxidase, glucose oxidase, glucose source, and a pH adjusting component as active ingredients is provided. The agent for protecting an upper respiratory tract according to the present invention and the food or drink composition for protecting an upper respiratory tract can ameliorate various symptoms relating to upper respiratory tracts.
    Type: Application
    Filed: July 15, 2016
    Publication date: October 4, 2018
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Kouichirou SHIN, Hiroyuki WAKABAYASHI, Masahiko KUROKAWA
  • Patent number: 10080377
    Abstract: The present disclosure provides a method for manufacturing an excellent denatured whey protein having no adverse effect on the characteristics of a product. A method for manufacturing a denatured whey protein comprising processing a whey protein solution by repeating the following steps (1) and (2) 2 times or more continuously: (1) a step for treating the whey protein solution on pressure at 50 MPa or higher and on heating at 85 to 100° C.; and, (2) a step for decompressing to 0.05 to 0.5 MPa after the treating of the aforementioned step (1) and maintaining the temperature within the range of the heating temperature of the aforementioned step (1) ±10° C.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: September 25, 2018
    Assignee: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Hiroshi Arase, Manabu Suzuki
  • Patent number: 10064903
    Abstract: The Lactobacillus paracasei MCC1849 (NITE BP-01633) strain, which has a high IL-12 production-promoting action, is used as an ingredient of a drug, food or drink, or feed used for promotion of IL-12 production, immunostimulation, antivirus, or the like.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: September 4, 2018
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Tomohiro Tanaka, Noriyuki Iwabuchi, Yohei Sato, Kanetada Shimizu, Toshitaka Odamaki
  • Patent number: 9944543
    Abstract: A power control device supplies electrolysis voltage and electrolysis current, based on input direct-current power, to an electrolytic cell for manufacturing electrolysis water by electrolysis on a raw material solution by means of electric current applied between an anode and a cathode.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: April 17, 2018
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Koki Matsuyama, Shigehiro Kobayashi
  • Patent number: 9903029
    Abstract: The invention is a bipolar-electrode electrolytic cell (1) which includes a chassis (2), an electrode plate (3) and a plate-shape spacer (4) having a concavity (25) disposing the electrode plate (3), wherein an unit cell (C), which is formed by connecting a plurality of spacers (4) in which the electrode plate (3) is disposed on the concavity (25) so that one plate surface of the electrode plate (3) is directed to one direction, is disposed inside the chassis (2). The bipolar-electrode electrolytic cell (1) includes engaged portions (35, 50 and 51) which are provided on any one of the concavity (25) of the spacer (4) or the electrode plate (3) and engaging portions (10A and 10B) which are formed the other portion with respect to the one portion.
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: February 27, 2018
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Koki Matsuyama, Yamato Matsuzaki
  • Patent number: 9894911
    Abstract: The present invention relates to a method for manufacturing a modified whey composition, the method having a liquid preparation step of preparing a raw material whey liquid using a whey composition containing whey protein, and a heating step of subjecting the raw material whey liquid to a heat treatment, wherein the liquid preparation step includes a treatment of adding an alkali to the whey composition, the pH of the raw material whey liquid is from 6.8 to 8.0 and the protein concentration in the liquid is not more than 1.3% by mass, the calcium content of the raw material whey liquid that is subjected to the heat treatment is from 400 to 700 mg/100 g of solids, and the heat treatment is performed under conditions of 80 to 150° C. for a period of 30 minutes to 1 second.
    Type: Grant
    Filed: June 14, 2013
    Date of Patent: February 20, 2018
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Mirei Odaka, Tomoya Murakami, Yohei Sakai, Kiyotaka Miyauchi, Hiroshi Koishihara
  • Patent number: 9801404
    Abstract: An extract of Citrus depressa, preferably a water and/or organic solvent extract of a fruit of leaf of Citrus depressa, a supercritical extract of a fruit of leaf of Citrus depressa, or a subcritical extract of a fruit of leaf of Citrus depressa, which comprise 0.3 mass % or more of a polymethoxyflavonoid more than in terms of solid matter, for example, an extract of Citrus depressa comprising 0.2 mass % or more of nobiletin and/or 0.1 mass % or more of tangeretin in terms of solid matter, or a polymethoxyflavonoid such as nobiletin or tangeretin is used as an active ingredient of an IGF-1 production-promoting agent.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: October 31, 2017
    Assignee: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Kazutaka Oshio, Hirohiko Nakamura, Yasuyuki Sakata
  • Patent number: 9643863
    Abstract: An electrolysis water-making apparatus (1) generates electrolyzed products by supplying a raw material solution into an electrolytic cell (4) to perform electrolysis, and generates electrolyzed water by diluting the electrolyzed products. The electrolysis water-making apparatus (1) includes a casing (20) configured to accommodate the electrolytic cell (4), and a bracket (30) fixed to the casing (20) in a freely detachable manner, and the bracket (30) includes a pair of rigid walls to which one end and the other end of the electrolytic cell (4) are attached. The pair of rigid walls have a dimension therebetween that can be adjusted according to the linear dimension of the electrolytic cell (4).
    Type: Grant
    Filed: June 20, 2016
    Date of Patent: May 9, 2017
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Koki Matsuyama, Tatsuya Midorikawa
  • Patent number: 9617300
    Abstract: An excellent peptidyl peptidase-IV inhibitor and the like are provided. A peptide consisting of Val-Pro-X wherein X represents an amino acid residue (except for L-proline residue); the aforementioned X is preferably one selected from a basic amino acid residue, an aliphatic neutral amino acid residue, an amide group-carrying neutral amino acid residue, or an aromatic group-carrying neutral amino acid residue; the aforementioned X is preferably one selected from an alanine residue, a glutamine residue, a methionine residue, an asparagine residue, a glycine residue, a valine residue, a tyrosine residue, a serine residue, and a lysine residue; a dipeptidyl peptidase-IV inhibitor, a blood sugar rise suppressing agent, a vascular endothelial disorder suppressing agent, and an angiotensin converting enzyme inhibitor containing the aforementioned peptide as an active ingredient.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: April 11, 2017
    Assignee: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Akio Yamada, Takuma Sakurai, Daisuke Ochi
  • Patent number: 9567625
    Abstract: Live cells of a microorganism in a test sample are detected by the following steps: a) the step of treating the test sample with a topoisomerase poison and/or a DNA gyrase poison, b) the step of extracting DNA from the test sample, and amplifying a target region of the extracted DNA by PCR, and c) the step of analyzing an amplification product.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: February 14, 2017
    Assignee: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Shinichi Yoshida, Takashi Soejima
  • Publication number: 20170013868
    Abstract: A major object of the present technology is to provide a technology for obtaining an aloe extract which has an excellent processability into foods and contains sufficient amounts of ?-sitosterol and aloe-derived dietary fibers as functional components. The present technology provides a method for manufacturing an aloe extract containing ?-sitosterol, phospholipids, and dietary fibers which involves carrying out: a homogenization step for homogenizing an aloe mesophyll solution; an enzymatic degradation step for adding a polysaccharide-degrading enzyme to the homogenized aloe mesophyll solution and degrading polysaccharides contained in the aforementioned homogenized aloe mesophyll solution; and a membrane filtration step for membrane-filtering the enzyme-degraded aloe mesophyll solution with a microfiltration membrane or an ultrafiltration membrane and recovering the retentate fraction as an aloe extract.
    Type: Application
    Filed: March 19, 2015
    Publication date: January 19, 2017
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventor: Naoki YUDA
  • Patent number: 9492424
    Abstract: An extract of Citrus depressa, preferably an organic solvent extract of a fruit and/or leaf of Citrus depressa, a supercritical extract of a fruit and/or leaf of Citrus depressa, or a subcritical extract of a fruit and/or leaf of Citrus depressa, containing 0.3 mass % or more of a polymethoxyflavonoid in terms of solid matter, for example, 0.2 mass % or more of nobiletin and/or 0.1 mass % or more of tangeretin in terms of solid matter, or a polymethoxyflavonoid, such as nobiletin and tangeretin, is used as an active ingredient of a muscle atrophy inhibitor.
    Type: Grant
    Filed: December 26, 2012
    Date of Patent: November 15, 2016
    Assignee: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Yasuyuki Sakata, Hirohiko Nakamura, Kazutaka Oshio
  • Patent number: 9440867
    Abstract: An electrolysis water-making apparatus (1) generates electrolyzed products by supplying a raw material solution into an electrolytic cell (4) to perform electrolysis, and generates electrolyzed water by diluting the electrolyzed products. The electrolysis water-making apparatus (1) includes a casing (20) configured to accommodate the electrolytic cell (4), and a bracket (30) fixed to the casing (20) in a freely detachable manner, and the bracket (30) includes a pair of rigid walls to which one end and the other end of the electrolytic cell (4) are attached. The pair of rigid walls have a dimension therebetween that can be adjusted according to the linear dimension of the electrolytic cell (4).
    Type: Grant
    Filed: May 23, 2011
    Date of Patent: September 13, 2016
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Koki Matsuyama, Tatsuya Midorikawa
  • Patent number: 9403699
    Abstract: The invention relates to an electrolysis water-making apparatus where an electrolytic cell in which a unit cell is provided in a casing, is fixed to an installation base by a fixture attached to the electrolytic cell, and, through a pipe group, electrolyte solution is supplied into the electrolytic cell, and electrolyzed products produced in the electrolytic cell are delivered. The electrolysis water-making apparatus is characterized in that: in the installation base, there are formed one or two or more through holes, depending on the size of the electrolytic cell, through which through hole the end part of the fixture can be inserted; an end part of the fixture is inserted through a through hole, which is selected from the one or two or more through holes depending on the size of the electrolytic cell; and an end part of the fixture which projects from the installation base is locked on the installation base.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: August 2, 2016
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventor: Koki Matsuyama
  • Patent number: 9399588
    Abstract: The electrolysis water-making apparatus (A) which is an apparatus for making electrolysis water (W5) by electrolyzing a raw material solution (W1, W3) including a chlorine ion includes: an electrolytic cell (2); a raw material solution feed pump (3) used to supply the raw material solution (W1, W3) to the electrolytic cell (2); and a pipe (32, 36) connecting an outlet (3b) of the raw material solution feed pump (3) allowing the raw material solution (W1, W3) to be discharged therefrom and an inlet (26) allowing the raw material solution (W1, W3) to flow into the electrolytic cell (2). In addition, the raw material solution feed pump (3) is provided so that the outlet (3b) is disposed on a lower side of the inlet (26).
    Type: Grant
    Filed: June 12, 2012
    Date of Patent: July 26, 2016
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Masayasu Shirato, Koki Matsuyama
  • Patent number: 9394572
    Abstract: Live cells of microorganism in a test sample are detected by distinguishing the live cells from dead cells or injured cells by the following steps of: a) adding an agent capable of covalently binding to DNA or RNA by irradiation with light having a wavelength of 350 nm to 700 nm to the test sample; b) irradiating the test sample to which the cross-linking agent is added with light having a wavelength of 350 nm to 700 nm; c) amplifying a target region of DNA or RNA of the microorganism contained in the test sample by a nucleic acid amplification method in the presence of an agent for suppressing an action of a nucleic acid amplification inhibitory substance, without extracting nucleic acids from the cells; and d) analyzing the amplified product.
    Type: Grant
    Filed: July 23, 2010
    Date of Patent: July 19, 2016
    Assignee: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Takashi Soejima, Frank Schlitt-Dittrich
  • Patent number: 9388060
    Abstract: The electrolysis water-making apparatus (A) includes: an electrolytic cell (2); a raw material solution feed pump (3) used to supply the raw material solution (W1, W3) to the electrolytic cell (2); a raw material solution pipe (32, 36) connecting an outlet (3b) of the raw material solution feed pump (3) and an inlet (26) of the electrolytic cell (2); and an electrolyzed solution advection-deterring portion (40) formed in the raw material solution pipe (32, 36) between the outlet (3b) and the inlet (26). The raw material solution feed pump (3) is provided so that the outlet (3b) is disposed on an upper side of the inlet (26). A pitched pipe (32c) in which an end thereof near the inlet (26) is disposed on an upper side of another end thereof near the outlet (3b) is provided in at least a part of the electrolyzed solution advection-deterring portion (40).
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: July 12, 2016
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Masayasu Shirato, Koki Matsuyama
  • Patent number: 9345743
    Abstract: A peptide dimer comprising a peptide consisting of the amino acid sequence of SEQ ID NO: 1 and a peptide consisting of any one of the amino acid sequences of SEQ ID NOS: 2 to 4, wherein the peptide consisting of the amino acid sequence of SEQ ID NO: 1 and the peptide consisting of any one of the amino acid sequences of SEQ ID NOS: 2 to 4 are bound through a disulfide bond between a cysteine residue of each peptide is used as an active ingredient of an agent for promoting proliferation of one or more bacterium selected from the group consisting of Bifidobacterium infantis and Bifidobacterium breve.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: May 24, 2016
    Assignee: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Hirotsugu Oda, Koji Yamauchi, Takumi Sato, Kanetada Shimizu